...
首页> 外文期刊>ACS applied materials & interfaces >Novel Chitosan-Functionalized Spherical Nanosilica Matrix As an Oral Sustained Drug Delivery System for Poorly Water-Soluble Drug Carvedilol
【24h】

Novel Chitosan-Functionalized Spherical Nanosilica Matrix As an Oral Sustained Drug Delivery System for Poorly Water-Soluble Drug Carvedilol

机译:新型壳聚糖功能化球形纳米二氧化硅基质作为水溶性差的药物卡维地洛的口服持续药物输送系统

获取原文
获取原文并翻译 | 示例

摘要

A novel spherical nanosilica matrix (SNM) together with chitosan (CTS) encapsulated SNM (CTS-SNM) was developed in order to investigate the feasibility of using chitosan to regulate drug release rate from porous silica and obtain an oral sustained drug delivery system. To achieve this goal, we synthesized a spherical nanosilica matrix (SNM) and incorporated chitosan chains on the SNM surface. Solvent evaporation method was adopted to load the model drug carvedilol into SNM and CTS-SNM. The physicochemical properties of the drug carriers and drug-loaded composites were systematically studied using scanning electron microscopy (SEM), transmission electron microscopy (TEM), nitrogen adsorption, X-ray diffraction (XRD), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). The structural changes in CTS-SNM in simulated gastrointestinal fluid as well as the relationships between swelling effect of chitosan and in vitro drug release behaviors were investigated. Pharmacokinetic and bioavailability aspects were also discussed. The results showed that the powerful dispersing effect of SNM and the blocking action due to the swelling of chitosan were the two main factors contributing to the sustained drug release behavior. The swelling effect of chitosan in an acidic environment together with the shrinking effect in a relatively alkaline environment allowed regulation of drug release behavior in simulated gastrointestinal fluid. An in vivo study showed that the bioavailability of CAR was improved 182% compared with that of the commercial capsule when SNM was used as the drug carrier. As for CAR-CTS-SNM, the T_(max) of CAR was delayed by about 3.4 h and the bioavailability was slightly increased in comparison with the commercial capsule. We believe that SNM and CTS-SNM developed in this study will help increase the use of polymers and inorganic materials in pharmaceutical applications and stimulate the design of oral drug delivery systems for immediate or sustained release of poorly water-soluble drugs.
机译:为了研究使用壳聚糖调节多孔二氧化硅的释药速率并获得口服持续给药系统的可行性,开发了一种新型球形纳米二氧化硅基质(SNM)和壳聚糖(CTS)封装的SNM(CTS-SNM)。为了实现此目标,我们合成了球形纳米二氧化硅基质(SNM),并在SNM表面上掺入了壳聚糖链。采用溶剂蒸发法将模型药物卡维地洛加载到SNM和CTS-SNM中。使用扫描电子显微镜(SEM),透射电子显微镜(TEM),氮吸附,X射线衍射(XRD),差示扫描量热法(DSC)和热重分析系统地研究了药物载体和载药复合物的理化性质分析(TGA)。研究了模拟胃肠道液中CTS-SNM的结构变化,以及壳聚糖的溶胀作用与体外药物释放行为之间的关系。还讨论了药物动力学和生物利用度方面。结果表明,SNM的强大分散作用和壳聚糖溶胀引起的阻断作用是造成药物持续释放行为的两个主要因素。壳聚糖在酸性环境中的溶胀作用以及在相对碱性环境中的收缩作用可以调节模拟胃肠液中的药物释放行为。体内研究表明,当将SNM用作药物载体时,与市售胶囊相比,CAR的生物利用度提高了182%。至于CAR-CTS-SNM,与商业胶囊相比,CAR的T_(max)延迟了约3.4小时,生物利用度略有增加。我们相信,这项研究中开发的SNM和CTS-SNM将有助于增加聚合物和无机材料在制药应用中的使用,并刺激设计用于立即或持续释放水溶性差的药物的口服药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号